Home »
1997 Issues »
62 FR (03/04/1997) » 97-5210. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amendment of Monograph for OTC Bronchodilator Drug Products; Correction
97-5210. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amendment of Monograph for OTC Bronchodilator Drug Products; Correction
[Federal Register Volume 62, Number 42 (Tuesday, March 4, 1997)]
[Rules and Regulations]
[Page 9684]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-5210]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 341
[Docket No. 94N-0247]
RIN 0910-AA01
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug
Products for Over-the-Counter Human Use; Amendment of Monograph for OTC
Bronchodilator Drug Products; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a final
monograph for over-the-counter (OTC) bronchodilator drug products that
appeared in the Federal Register of May 20, 1996 (61 FR 25142). The
document amended the final monograph for OTC bronchodilator drug
products by removing pressurized metered-dose aerosol container dosage
forms for the ingredients epinephrine, epinephrine bitartrate, and
racepinephrine hydrochloride. The document was published with an
inadvertent error in one of the amendatory instructions. This document
corrects that error.
EFFECTIVE DATE: March 4, 1997.
FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy
(HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD
20857, 301-443-2994.
SUPPLEMENTARY INFORMATION: In FR Doc. 96-12499, appearing on page 25142
in the Federal Register of Monday, May 20, 1996, the following
correction is made: On page 25146, in the 3d column, amendatory
instruction 4 is corrected to read as follows:
4. Section 341.76 is amended by removing the heading for paragraph
(d)(2), and paragraphs (d)(2)(i) and (e), by redesignating paragraph
(d)(2)(ii) as paragraph (d)(2), and by revising the heading of newly
redesignated paragraph (d)(2) to read as follows:
Dated: February 24, 1997.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 97-5210 Filed 3-3-97; 8:45 am]
BILLING CODE 4160-01-F
Document Information
- Effective Date:
- 3/4/1997
- Published:
- 03/04/1997
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule; correction.
- Document Number:
- 97-5210
- Dates:
- March 4, 1997.
- Pages:
- 9684-9684 (1 pages)
- Docket Numbers:
- Docket No. 94N-0247
- RINs:
- 0910-AA01: Over-the-Counter (OTC) Drug Review
- RIN Links:
- https://www.federalregister.gov/regulations/0910-AA01/over-the-counter-otc-drug-review
- PDF File:
-
97-5210.pdf
- CFR: (1)
- 21 CFR 341